The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(5-methyl-1H-imidazol-4-yl)-9H-pyrido[3,4-b]indole ID: ALA5200447
Max Phase: Preclinical
Molecular Formula: C15H12N4
Molecular Weight: 248.29
Associated Items:
Names and Identifiers Canonical SMILES: Cc1[nH]cnc1-c1nccc2c1[nH]c1ccccc12
Standard InChI: InChI=1S/C15H12N4/c1-9-13(18-8-17-9)15-14-11(6-7-16-15)10-4-2-3-5-12(10)19-14/h2-8,19H,1H3,(H,17,18)
Standard InChI Key: JYMJXRXSEUMGMU-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 22 0 0 0 0 0 0 0 0999 V2000
-1.6548 2.1744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9402 2.5867 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2283 2.1748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2283 1.3496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9384 0.9378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6548 1.3459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3882 0.7824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0606 0.0511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7593 0.1414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.1853 0.8644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6548 0.2151 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3273 -0.5162 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.5302 -0.5982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1295 -1.2920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5302 -1.9859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0245 -2.5867 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7377 -2.2656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6481 -1.4654 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3314 -1.9859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
4 7 1 0
7 8 2 0
9 8 1 0
5 9 1 0
7 10 1 0
11 10 2 0
12 11 1 0
13 12 2 0
8 13 1 0
13 14 1 0
15 14 2 0
15 16 1 0
16 17 1 0
18 17 2 0
14 18 1 0
15 19 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 248.29Molecular Weight (Monoisotopic): 248.1062AlogP: 3.41#Rotatable Bonds: 1Polar Surface Area: 57.36Molecular Species: NEUTRALHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.36CX Basic pKa: 3.97CX LogP: 2.37CX LogD: 2.37Aromatic Rings: 4Heavy Atoms: 19QED Weighted: 0.54Np Likeness Score: 0.01
References 1. Aaghaz S, Sharma K, Jain R, Kamal A.. (2021) β-Carbolines as potential anticancer agents., 216 [PMID:33684825 ] [10.1016/j.ejmech.2021.113321 ] 2. Beato A, Gori A, Boucherle B, Peuchmaur M, Haudecoeur R.. (2021) β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer's Disease Therapy., 64 (3.0): [PMID:33528252 ] [10.1021/acs.jmedchem.0c01887 ] 3. Luo B, Song X.. (2021) A comprehensive overview of β-carbolines and its derivatives as anticancer agents., 224 [PMID:34332400 ] [10.1016/j.ejmech.2021.113688 ]